Adjunctive Antidepressant Use in Bipolar Disorder and Its Clinical Correlates: An Asian Psychotropic Prescription Patterns Consortium Study
- 9 June 2025
- journal article
- research article
- Published by Wiley in Asia-Pacific Psychiatry
- Vol. 17 (2) , e70004
Abstract
Introduction: Adjunctive antidepressant (AD) use is prevalent for the treatment of bipolar disorder (BD) in many countries, but there is little information about this practice in Asia. Accordingly, we addressed the prevalence, dosing, and clinical correlates of adjunctive AD use with BD in a large Asian sample.Methods: Patients with BD were recruited across 13 Asian sites (PR China, Hong Kong, India, Indonesia, Japan, South Korea, Malaysia, Myanmar, Pakistan, Singapore, Sri Lanka, Taiwan, and Thailand) for this cross‐sectional study. We examined differences between patients with versus without adjunctive AD treatment. Multivariable logistic regression was used to identify factors associated with the use of adjunctive AD.Results: Among a total of 2114 adult participants (47.7% men; age 42.4 years [CI: 41.8–43.0]; BMI 25.0 kg/m2 [24.8–25.2]), the prevalence of AD use averaged 19.8% [18.1–21.6], at a mean imipramine‐equivalent dose of 113 [110–116] mg/day. Adjunctive AD use was associated with factors including older age, outpatient status, more depression, suicidal behavior, rapid cycling, and lower doses of MS and antipsychotics (APs).Discussion: Usage of AD treatment for BD in Asia was less than half that reported in Western samples. Such use of AD treatment appeared to be well tolerated but underscores the need for close clinical follow‐up to avoid risks of excessive elevation of mood or behavior.Keywords
Funding Information
- Bruce J. Anderson Foundation
This publication has 36 references indexed in Scilit:
- Real-world use of pharmacological treatments for incident bipolar disorder: A Finnish nationwide cohort studyJournal of Affective Disorders, 2023
- A systematic review of manic/hypomanic and depressive switches in patients with bipolar disorder in naturalistic settings: The role of antidepressant and antipsychotic drugsEuropean Neuropsychopharmacology, 2023
- Prescribing changes for bipolar patients discharged from two public psychiatric hospitals in Taiwan, 2006–2019Journal of Affective Disorders, 2022
- Bipolar disorder prevalence and psychotropic medication utilisation in Hong Kong and the United KingdomPharmacoepidemiology and Drug Safety, 2021
- Depressive symptoms in early‐ and late‐onset older bipolar patients compared with younger onesInternational Journal of Geriatric Psychiatry, 2016
- Psychopharmacological treatment of 1650 in-patients with acute mania-data from the AMSP studyJournal of Affective Disorders, 2016
- Long-term morbidity in bipolar-I, bipolar-II, and unipolar major depressive disordersJournal of Affective Disorders, 2015
- Medication burden in bipolar disorder: A chart review of patients at psychiatric hospital admissionPsychiatry Research, 2014
- Bipolar depression: Clinical correlates of receiving antidepressantsJournal of Affective Disorders, 2012
- Antidepressant-associated chronic irritable dysphoria (ACID) in STEP-BD patientsJournal of Affective Disorders, 2008